Russell Angus C. Insider Trades

Insider Trading History

Track insider trading activity for Russell Angus C.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Director
Holding Value $90.8k 75,000 shares
Last Trade
Jul 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$67.5k 75,000 shares
$0.90
$1.21
Structure Therapeutics
Structure Therapeutics GPCR
Director
Holding Value $1.67M 42,833 shares
Last Trade
Jun 23, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$947k 42,833 shares
$22.10
$39.06
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $0 0 shares
Last Trade
Feb 06, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$54.8k 15,000 shares
$3.65
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $54.8k 15,000 shares
Last Trade
Feb 04, 2025 Sale (Tender)Reported as Tender on SEC Form 4.
$133k 36,506 shares
$3.65
$3.65
Structure Therapeutics
Structure Therapeutics GPCR
Director
Holding Value $2.93M 75,000 shares
Last Trade
Aug 26, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.05M 75,000 shares
$40.60
$39.06
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Director
Holding Value $90.8k 75,000 shares
Last Trade
Jul 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$71.3k 75,000 shares
$0.95
$1.21
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $188k 51,506 shares
Last Trade
May 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$89.1k 23,458 shares
$3.80
$3.65
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Director
Holding Value $60.5k 50,000 shares
Last Trade
Jul 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$70.5k 50,000 shares
$1.41
$1.21
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $133k 36,506 shares
Last Trade
May 03, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$199k 5,915 shares
$33.61
$3.65
TherapeuticsMD
TherapeuticsMD TXMD
Director
Holding Value $10k 5,000 shares
Last Trade
Sep 29, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$33.7k 5,000 shares
$6.73
$2.00
TherapeuticsMD
TherapeuticsMD TXMD
Director
Holding Value $11.6k 5,792 shares
Last Trade
Aug 18, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$20.3k 1,984 shares
$10.22
$2.00
TherapeuticsMD
TherapeuticsMD TXMD
Director
Holding Value $0 0 shares
Last Trade
Aug 18, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$20.3k 1,984 shares
$10.22
$2.00
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Director
Holding Value $60.5k 50,000 shares
Last Trade
Jul 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$157k 100,000 shares
$1.57
$1.21
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $39.3k 10,756 shares
Last Trade
May 04, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$195k 10,756 shares
$18.12
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $120k 32,972 shares
Last Trade
May 04, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$315k 17,402 shares
$18.12
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $98.2k 26,913 shares
Last Trade
Dec 13, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$101k 6,400 shares
$15.74
$3.65
TherapeuticsMD
TherapeuticsMD TXMD
Director
Holding Value $0 0 shares
Last Trade
Aug 10, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$4.45M 96,864 shares
$45.96
$2.00
TherapeuticsMD
TherapeuticsMD TXMD
Director
Holding Value $381k 190,364 shares
Last Trade
Aug 10, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$4.45M 96,864 shares
$45.96
$2.00
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Director
Holding Value $60.5k 50,000 shares
Last Trade
Jul 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$143k 50,000 shares
$2.86
$1.21
TherapeuticsMD
TherapeuticsMD TXMD
Director
Holding Value $198k 99,174 shares
Last Trade
Jul 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6M 99,174 shares
$60.50
$2.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up